sk&f 86002 has been researched along with alpha-synuclein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cookson, MR; Ding, J; Figg, WD; Horan-Portelance, L; Iba, M; Kim, C; Kwon, S; Lee, SJ; Masliah, E; Overk, C; Peer, CJ; Reed, X; Rissman, RA; Szabo, M; Wrasidlo, W | 1 |
1 other study(ies) available for sk&f 86002 and alpha-synuclein
| Article | Year |
|---|---|
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.
Topics: alpha-Synuclein; Animals; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Neuroinflammatory Diseases; Neurons; Parkinson Disease | 2023 |